Samsung Biologics Co.,Ltd. (207940.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

32.4x

EV/EBITDA

22.8x

Market Cap

KRW 68.30T

MomentumView details →

1D Return

−1.60%

YTD Return

−14.63%

RSI (14)

41.5

ValuationView details →

P/E (Fwd)

32.4x

EV/EBITDA

22.8x

Market Cap

KRW 68.30T

RSI (14)

41.5

MomentumView details →

1D Return

−1.60%

YTD Return

−14.63%

ProfitabilityView details →

Gross Margin

55.54%

Net Margin

43.64%

EBITDA Margin

64.97%

ROE (TTM)

23.73%

ROA (TTM)

15.68%

Asset Turnover

0.37x

GrowthView details →

Revenue YoY

−9.64%

EPS YoY

+54.40%

FCF YoY

+293.08%

Revenue CAGR 3Y

+14.94%

EPS CAGR 3Y

+29.93%

EBITDA YoY

+31.89%

EarningsView details →

EPS (Actual)

KRW 9,304.19

EPS Surprise

−3.93%

Beats (12Q)

0/12

Next Q EPS Est

KRW 9,978.26

Avg Surprise (4Q)

−3.93%

Rev Surprise

0.85%

Capital & dividendView details →

Debt/Equity

0.15x

Current Ratio

1.80x

Quick Ratio

1.01x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

4.55T

Net Income (TTM)

1.98T

Op. CF (TTM)

2.43T

Next earningsOct 27, 2026 →

Latest newsMore news →

No recent news for 207940.KS.

Similar companies

Celltrion, Inc.068270.KS ALTEOGEN Inc.196170.KQ Samsung Epis Holdings0126Z0.KS SK Biopharmaceuticals Co., Ltd.326030.KS HLB Co., Ltd.028300.KQ PharmaResearch Co., Ltd.214450.KQ Find similar companies →

Latest newsMore news →

No recent news for 207940.KS.